Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares fell 55.7% on Monday . The company traded as low as $2.70 and last traded at $3.00. 3,378 shares were traded during trading, a decline of 63% from the average session volume of 9,053 shares. The stock had previously closed at $6.77.
Peak Pharmaceuticals Stock Performance
The business’s 50-day moving average is $3.68 and its two-hundred day moving average is $2.32.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Articles
- Five stocks we like better than Peak Pharmaceuticals
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How to start investing in penny stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
